Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 21

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

406

HTML

3253

Figures (1-2)

212

Tables (1-3)

207

Sum=4078

Publishing Process of This Article

Item

Count

Browse

690

Download

735

Sum=1425

Jun 7, 2013 (publication date) through Dec 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jun 7, 2013; 19(21): 3255-3262
Published online Jun 7, 2013. doi: 10.3748/wjg.v19.i21.3255

Table 3 Reported liver-related and treatment-related adverse events

	Non-liver transplanted cirrhotics	Liver transplanted cirrhotics
Intolerance (fatigue, flu-like symptoms, depression)
Grade 2	1	0
Grade 3	3	0
Anemia
Grade 1	12	0
Grade 2	2	4
Grade 3	0	2
Neutropenia
Grade 2	0	2
Grade 3	6	1
Liver decompensation
Grade 1 (encephalopathy)	0	1
Other
Hepatocellular carcinoma	2	0
Polytrauma	1	0

Citation: Ponziani FR, Annicchiarico EB, Siciliano M, D’Aversa F, Pompili M, Gasbarrini A. Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation. World J Gastroenterol 2013; 19(21): 3255-3262
URL: https://www.wjgnet.com/1007-9327/full/v19/i21/3255.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i21.3255